Original Research
Published on 30 Mar 2015
Global impact of KRAS mutation patterns in FOLFOX treated metastatic colorectal cancer
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2015.00116
- 9,336 views
- 32 citations
Type at least 3 characters
172 articles
Articles
Original Research
Published on 27 Feb 2015
CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2015.00046
- 7,705 views
- 15 citations
Review
Published on 18 Feb 2015
Use of pharmacogenomics in pediatric renal transplant recipients
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2015.00041
- 6,794 views
- 12 citations
Review
Published on 04 Feb 2015
ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2015.00017
- 10,417 views
- 35 citations
Original Research
Published on 22 Jan 2015
HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: evidence for high risk of drug-induced hypersensitivity
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2014.00478
- 8,729 views
- 34 citations
Original Research
Published on 13 Jan 2015
Identification of genetic variants or genes that are associated with Homoharringtonine (HHT) response through a genome-wide association study in human lymphoblastoid cell lines (LCLs)
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2014.00465
- 5,386 views
- 4 citations
Mini Review
Published on 14 Nov 2014
Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2014.00391
- 8,739 views
- 25 citations
Mini Review
Published on 04 Nov 2014
Genetic polymorphism in the NRF2 gene as a prognosis marker for cancer chemotherapy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2014.00383
- 8,721 views
- 25 citations
Review
Published on 14 Oct 2014
Pharmacogenomics of acetaminophen in pediatric populations: a moving target
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2014.00314
- 15,577 views
- 36 citations
Review
Published on 27 Aug 2014
Persistent pharmacokinetic challenges to pediatric drug development
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2014.00281
- 10,536 views
- 29 citations
Original Research
Published on 04 Jun 2014
Genetic variation in the 3′-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2, and UGT2B7: potential effects on regulation by microRNA and pharmacogenomics relevance
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2014.00167
- 8,308 views
- 39 citations
Methods
Published on 24 Apr 2014
Detection of large expansions in myotonic dystrophy type 1 using triplet primed PCR
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2014.00094
- 17,025 views
- 17 citations
Review
Published on 16 Apr 2014
Pharmacogenomics and adverse drug reactions in children
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2014.00078
- 16,869 views
- 25 citations
Mini Review
Published on 08 Apr 2014
Pharmacogenomics in oncology care
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2014.00073
- 17,472 views
- 36 citations
Original Research
Published on 25 Mar 2014
CYP2C8 and CYP2C9 mRNA expression profile in the human fetus
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2014.00058
- 5,148 views
- 14 citations
Original Research
Published on 14 Nov 2013
Genetic Associations with 25-Hydroxyvitamin D Deficiency in HIV-1-Infected Youth: Fine-Mapping for the GC/DBP Gene That Encodes the Vitamin D-Binding Protein
in Pharmacogenetics and Pharmacogenomics
Frontiers in Genetics
doi 10.3389/fgene.2013.00234
- 4,539 views
- 5 citations